Key facts
- PathPresenter’s last known valuation is $25.0M.
- It has raised $8.5M; the latest was Later Stage VC ($7.5M) in Aug 2024.
- Notable investors include Modi Ventures, Avant Bio, Barco.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for PathPresenter
- ·The full record, as it builds
Funding rounds
No funding rounds for PathPresenter are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PathPresenter
Developer of image-sharing technology designed to connect pathologists to the vast expertise of their colleagues globally. The company's platform provides a secure and HIPAA-compliant environment for sharing medical images, enabling pathologists to collaborate more effectively and provide care for their patients.
- Sector
- Healthcare
- HQ
- Montville, NJ, United States
- Founded
- 2017
- Employees
- 32
- Website
- pathpresenter.com/
- Ownership
- Privately Held (backing)
PathPresenter doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PathPresenter shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PathPresenter in its N-PORT filings yet. We sweep new filings monthly.